NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

輸尿管鏡市場:2021年∼至2026年的預測

Ureteroscope Market - Forecasts from 2021 to 2026

出版商 Knowledge Sourcing Intelligence 商品編碼 1023161
出版日期 內容資訊 英文 116 Pages
商品交期: 最快1-2個工作天內
價格
輸尿管鏡市場:2021年∼至2026年的預測 Ureteroscope Market - Forecasts from 2021 to 2026
出版日期: 2021年07月13日內容資訊: 英文 116 Pages
簡介

全球輸尿管鏡的市場規模,2019年價值3億6017萬8000美元,今後預計以4.33%的年複合成長率成長,2026年達到4億8471萬3000美元的市場規模。

最近發生的新型冠狀病毒感染疾病,給予全球輸尿管鏡市場負面影響。因此大流行,醫療系統的主要焦點轉移到COVID-19,作為COVID-19法規的一環,不得不中止全球各地大量的手術,2020年的全球輸尿管鏡市場減少了。可是,全球大部分的地區法規正逐漸緩和,市場恢復,預計2022年後以通常的步調發展。

本報告提供全球輸尿管鏡市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各類型,各地區的市場規模的變化與預測,競爭情形,並提供主要企業簡介等資訊。

目錄

第1章 簡介

  • 市場定義
  • 市場區隔

第2章 調查手法

  • 調查資料
  • 假設

第3章 摘要整理

  • 調查的重點

第4章 市場動態

  • 市場推動因素
  • 市場阻礙因素
  • 波特的五力分析
    • 終端用戶談判力
    • 買方議價能力
    • 新加入業者的威脅
    • 替代品的威脅
    • 產業的競爭企業間的敵對關係
  • 產業的價值鏈分析

第5章 各類型的全球輸尿管鏡市場分析

  • 簡介
  • 軟式輸尿管鏡
  • 硬式輸尿管鏡
  • 半硬性輸尿管鏡

第6章 各應用領域的全球輸尿管鏡市場分析

  • 簡介
  • 尿結石
  • 腎臟癌症
  • 尿道狹窄
  • 其他

第7章 各終端用戶的全球輸尿管鏡市場分析

  • 簡介
  • 醫院及診療所
  • 門診病人手術中心
  • 診斷中心

第8章 各地區全球輸尿管鏡市場分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 台灣
    • 泰國
    • 印尼
    • 其他

第9章 競爭環境與分析

  • 主要的參與者與策略分析
  • 新興參與者和市場收益性
  • 合併,收購,協定,及合作
  • 供應商競爭力矩陣

第10章 企業簡介

  • Boston Scientific Corporation
  • Olympus Corporation
  • Richard Wolf GmbH
  • PENTAX Medical
  • Clarion Medical Technologies
  • NeoScope Inc.
  • Maxiflex LLC
  • Stryker
  • ELMED Medical Systems
  • Dornier MedTech
目錄
Product Code: KSI061611831

The global ureteroscope market is evaluated at US$360.178 million for the year 2019 and is projected to grow at a CAGR of 4.33% to reach a market size of US$484.713 million by the year 2026. Ureteroscope is a small size instrument inserted into the bladder and ureter to diagnose and treat a variety of problems in the urinary tract. The purview of ureteroscopy has broadened from diagnostic endoscopy to various minimally invasive procedures. Growth in the ureteroscope market is significantly driven by the rising incidence of urolithiasis coupled with the increasing prevalence of urologic cancers. Also, the growing adoption and demand for minimally invasive procedures are anticipated to play a crucial role in augmenting the market growth during the forecast period. Moreover, the rise in research and development activities in ureteroscope is expected to boost the growth of the global ureteroscope market. However, the high cost of ureteroscope is expected to hinder the market growth. Furthermore, the rising prevalence of obesity, diabetes, and a growing geriatric population is expected to surge the incidences of diseases of the urinary tract, which in turn is anticipated to propel the global ureteroscope market growth during the assessment period.

The recent outbreak of the novel coronavirus disease had a negative impact on the global ureteroscope market. The pandemic shifted the major focus of the healthcare system towards COVID-19 and as part of the COVID-19 restrictions, a large number of surgeries had to be canceled in many parts of the world, which led to a decline in the global ureteroscope market in 2020. However, as the restrictions are being eased in most parts of the world, the market is anticipated to recover and continue at its normal pace from the year 2022 onwards.

Rising prevalence of urolithiasis.

One of the major factors anticipated to drive the growth of the global ureteroscope market during the forecast period is the growing number of cases of urolithiasis, which is expected to surge the demand for ureteroscope. According to an article published in the Journal of Family Medicine and Primary Care in December 2020, the prevalence of urolithiasis has been increasing around the world with a prevalence of 7-13% in North America, 5-9% in Europe 5-9%, and 1-5% in Asia. It also states that the United States will have an expected additional expenditure of $1.24 billion/year by 2030 due to a rise in the number of cases of urolithiasis. An article published by Advanced Biomedical Research in the US National Library of Medicine, National Institutes of Health showed that diabetes increases the risk of urolithiasis. As per International Diabetes Federation, 9.3% of the global population i.e., 463 million people had diabetes in 2019, which is projected to increase to 10.2% i.e. 578 million by 2030 and 10.9% i.e. 700 million by 2045. This is leading to an increased prevalence of urolithiasis, which is anticipated to propel the growth of the global ureteroscope market during the assessment period.

Growing demand for minimally invasive surgeries.

The rise in the adoption and demand for minimally invasive surgeries, due to its various advantages over traditional surgeries, is prompting increased use of ureteroscope which is anticipated to propel the growth of the global ureteroscope market during the forecast period. The minimally invasive surgery requires smaller incisions and consequently less scarring which are some of the reasons for its rising preference. The minimally invasive surgeries reduce the hospital stay time for the patient and have shorter recovery periods, along with providing increased accuracy, which is prompting the demand for minimally invasive surgeries. Another article published in February 2020 in US NLM, NIH, showed that the open surgical procedures declined by nearly 35% from 2000 to 2018 and are being replaced by minimally invasive surgeries. This rising demand is expected to grow further in the coming years and is anticipated to boost the global ureteroscope market growth during the forecast period.

North America to hold a significant market share.

Geographically, the North American region is anticipated to hold a significant market share owing to a large presence of conditions that lead to urolithiasis and other complications requiring the use of a ureteroscope. The United States has a high prevalence of diabetes that increases the risk of urolithiasis, which is one of the reasons for the high market share of North America. Also, the presence of an advanced healthcare system contributed to the domination of North America in the global ureteroscope market. The Asia Pacific region is anticipated to witness substantial growth due to rising cases of urolithiasis in the region and the increasing number of people with obesity. Also, the increased expenditure in the healthcare industry is further anticipated to propel the market growth in the Asia Pacific during the forecast period.

Market Segmentation:

  • By Type

Flexible Ureteroscope

Rigid Ureteroscope

Semi-Rigid Ureteroscope

  • By Application

Urolithiasis

Kidney Cancer

Urinary Stricture

Others

  • By End-User

Hospitals and Clinics

Ambulatory Surgical Centers

Diagnostic Centers

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Global Ureteroscope Market Analysis, by Type

  • 5.1. Introduction
  • 5.2. Flexible Ureteroscope
  • 5.3. Rigid Ureteroscope
  • 5.4. Semi-Rigid Ureteroscope

6. Global Ureteroscope Market Analysis, by Application

  • 6.1. Introduction
  • 6.2. Urolithiasis
  • 6.3. Kidney Cancer
  • 6.4. Urinary Stricture
  • 6.5. Others

7. Global Ureteroscope Market Analysis, by End-User

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Diagnostic Centers

8. Global Ureteroscope Market Analysis, by Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. UK
    • 8.4.4. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Taiwan
    • 8.6.6. Thailand
    • 8.6.7. Indonesia
    • 8.6.8. Others

9. Competitive Environment and Analysis

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Market Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Vendor Competitiveness Matrix

10. Company Profiles

  • 10.1. Boston Scientific Corporation
  • 10.2. Olympus Corporation
  • 10.3. Richard Wolf GmbH
  • 10.4. PENTAX Medical
  • 10.5. Clarion Medical Technologies
  • 10.6. NeoScope Inc.
  • 10.7. Maxiflex LLC
  • 10.8. Stryker
  • 10.9. ELMED Medical Systems
  • 10.10. Dornier MedTech